Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder
Evaluation of Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder: a Randomized Controlled Trial
Iffat Anwar Medical Complex
100 participants
Aug 13, 2024
INTERVENTIONAL
Conditions
Summary
This randomized controlled trial aims to evaluate the efficacy of a combination of photo-biomodulation at acupuncture points, autologous platelet-rich plasma (PRP), and umbilical cord-derived exosome therapy in children with Autism Spectrum Disorder (ASD). The study will compare these interventions against standard care to determine their impact on the severity of autism symptoms, as measured by the Childhood Autism Rating Scale (CARS) and other related markers.
Eligibility
Inclusion Criteria4
- Diagnosis of Autism Spectrum Disorder based on DSM-5 criteria
- Age 3-12 years
- Stable on current medications for at least 4 weeks prior to study entry
- Parents or legal guardians willing to provide informed consent
Exclusion Criteria4
- Severe comorbid medical conditions
- Prior stem cell or exosome therapy
- History of hypersensitivity to any component of the interventions
- Inability to comply with study procedures
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Application at acupuncture points for 20 seconds each week. using 810nm Laser probe
IV injection of Autologous Plasma Rich Platelets (PRP) on Days 0, 15, 30, and 45.
IV injection of Umbilical Cord-Derived Exosomes at laser acupuncture points Umbilical Cord-Derived Exosomes
Routine conventional including Applied Behavioral Analysis (ABA) for Autism Spectrum Disorder (ASD)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06600529